Search

The NOD1/2‐RIPK2 is a key cytosolic signaling complex that activates NF‐κB pro‐inflammatory response against invading pathogens. However, uncontrolled NF‐κB signaling can cause tissue damage leading to chronic diseases. The mechanisms by which the NODs‐RIPK2‐NF‐κB innate immune axis is activated and resolved remain poorly understood. Here, we demonstrate that bacterial infection induces the formation of endogenous RIPK2 oligomers (RIPosomes) that are self‐assembling entities that coat the bacteria to induce NF‐κB response. Next, we show that autophagy proteins IRGM and p62/SQSTM1 physically interact with NOD1/2, RIPK2 and RIPosomes to promote their selective autophagy and limit NF‐κB activation. IRGM suppresses RIPK2‐dependent pro‐inflammatory programs induced by Shigella and Salmonella. Consistently, the therapeutic inhibition of RIPK2 ameliorates Shigella infection‐ and DSS‐induced gut inflammation in Irgm1 KO mice. This study identifies a unique mechanism where the innate immune proteins and autophagy machinery are recruited together to the bacteria for defense as well as for maintaining immune homeostasis. Synopsis: Bacterial infection induces the formation of RIPosomes (RIPK2 oligomers) that are recruited to the bacteria to enhance the NF‐κB response. To maintain innate immune homeostasis, RIPosomes undergo selective autophagy mediated by autophagy proteins, IRGM, and p62/SQSTM1. RIPosomes are self‐assembling structures that are formed upon bacterial infection and coat bacteria to induce NF‐κB response.IRGM‐ and p62‐mediated selective autophagy degrades NODs, RIPK2, and RIPosomes to suppress NF‐κB response.IRGM suppresses RIPK2‐dependent NF‐κB and interferon responses upon Shigella‐ and Salmonella infection.RIPK2 inhibition using GSK583 ameliorates shigellosis‐ and DSS‐induced gut inflammation in Irgm1KO mice [ABSTRACT FROM AUTHOR]

Extensive crosstalk exists between autophagy and innate immune signalling pathways. The stimuli that induce pattern recognition receptor (PRR)‐mediated innate immune signalling pathways, also upregulate autophagy. The purpose of this increased autophagy is to eliminate the stimuli and/or suppress the inflammatory pathways by targeted degradation of PRRs or intermediary proteins (termed 'inflammophagy'). By executing these functions, autophagy dampens excess inflammation triggered by the innate immune signalling pathways. Thus, autophagy helps in the maintenance of the body's innate immune homeostasis to protect from inflammatory and autoimmune diseases. Many autophagy‐dependent mechanisms that could control innate immune signalling have been studied over the last few years. However, still, the understanding is incomplete, and studies that are more systematic should be undertaken to delineate the mechanisms of inflammophagy. Here, we discuss the available knowledge of crosstalk between autophagy and PRR signalling pathways. [ABSTRACT FROM AUTHOR]